Study of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma

NCT00413075 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

121

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor
Lymphoma

Interventions

DRUG: oral belinostat

Sponsor

Valerio Therapeutics

Collaborators

[object Object]